Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 5
2004 4
2005 2
2006 3
2007 2
2008 3
2009 4
2010 7
2011 11
2012 4
2013 5
2014 4
2015 11
2016 8
2017 2
2018 13
2019 8
2020 19
2021 12
2022 13
2023 16
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Results by year

Filters applied: . Clear all
Page 1
Genetic backgrounds and clinical characteristics of congenital neutropenias in Israel.
Yeshareem L, Yacobovich J, Lebel A, Noy-Lotan S, Dgany O, Krasnov T, Berger Pinto G, Oniashvili N, Mardoukh J, Bielorai B, Laor R, Mandel-Shorer N, Ben Barak A, Levin C, Asleh M, Miskin H, Revel-Vilk S, Levin D, Benish M, Zuckerman T, Wolach O, Pazgal I, Brik Simon D, Gilad O, Yanir AD, Goldberg TA, Izraeli S, Tamary H, Steinberg-Shemer O. Yeshareem L, et al. Among authors: revel vilk s. Eur J Haematol. 2024 Apr 11. doi: 10.1111/ejh.14197. Online ahead of print. Eur J Haematol. 2024. PMID: 38600884
Venglustat in GBA1-related Parkinson's disease.
Zimran A, Revel-Vilk S, Becker-Cohen M, Istaiti M, Rolfs A. Zimran A, et al. Among authors: revel vilk s. Lancet Neurol. 2024 Feb;23(2):137. doi: 10.1016/S1474-4422(23)00455-6. Lancet Neurol. 2024. PMID: 38267177 No abstract available.
Insights into the Value of Lyso-Gb1 as a Predictive Biomarker in Treatment-Naïve Patients with Gaucher Disease Type 1 in the LYSO-PROOF Study.
Curado F, Rösner S, Zielke S, Westphal G, Grittner U, Skrahina V, Alasel M, Malik AM, Beetz C, Böttcher T, Barel G, Sah AP, Dinur T, Anjum N, Ichraf Q, Kriouile Y, Hadipour Z, Hadipour F, Revel-Vilk S, Cozma C, Hartkamp J, Cheema H, Zimran A, Bauer P, Rolfs A; LYSO-PROOF Study Group. Curado F, et al. Among authors: revel vilk s. Diagnostics (Basel). 2023 Aug 30;13(17):2812. doi: 10.3390/diagnostics13172812. Diagnostics (Basel). 2023. PMID: 37685353 Free PMC article.
Pediatric overweight and obesity increased in Israel during the COVID-19 period.
Rose A, Mor EE, Krieger M, Ben-Yehuda A, Revel-Vilk S, Cohen AD, Matz E, Bar-Ratson E, Bareket R, Paltiel O, Calderon-Margalit R. Rose A, et al. Among authors: revel vilk s. PLoS One. 2023 Sep 5;18(9):e0290961. doi: 10.1371/journal.pone.0290961. eCollection 2023. PLoS One. 2023. PMID: 37669279 Free PMC article.
141 results